This article is mentioned in:

Introduction

Tongue squamous cell carcinoma (TSCC) is the most common type of oral cancer and accounts for ~25-50% of all oral cancer cases (1,2). It is characterized by unlimited growth and rapid local invasion and frequently causes dysfunction of mastication, speech and deglutition (3,4). Currently, surgery, chemotherapy and radiotherapy are the primary treatment strategies for patients with TSCC (5). Unfortunately, the overall survival rate of patients with TSCC has only improved slightly in previous decades despite notable progress in treatment techniques; currently, such patients have a 5-year survival rate of 50% (6). Local or distant metastasis and recurrence are the most common causes of mortality in patients with TSCC (7). Another important reason is that approximately one-half of patients with TSCC are diagnosed at an advanced stage, and these patients are not eligible for surgical treatment (2). Therefore, the mechanisms underlying the pathogenesis and development of TSCC require further investigation as they may provide information that may be useful in identifying novel therapeutic methods for patients with TSCC.

MicroRNAs (miRNAs) are a type of endogenous, single-stranded, noncoding short RNA molecules containing 18–25 nucleotides (8). These highly conserved miRNAs are involved in the regulation of gene expression by causing mRNA degradation or suppressing translation by directly binding to the 3′-untranslated regions (3′-UTRs) of their target genes in a base-pairing manner (9). Approximately one-half of miRNAs are located at cancer-associated chromosomal regions and may thus be closely linked to tumorigenesis and tumor development (10). The expression levels of miRNAs are altered in various human malignancies, including TSCC (11), prostate cancer (12), lung cancer (13) and thyroid cancer (14). Emerging studies report that multiple miRNAs are upregulated or downregulated in TSCC (15–17). Meanwhile, dysregulated miRNAs may act as oncogenes or tumor suppressors and serve crucial roles in TSCC formation and progression (18,19). Therefore, in-depth investigation of the detailed roles of miRNAs and their underlying mechanisms in TSCC is likely to provide therapeutic targets for the treatment of patients with this aggressive disease.

miRNA (miR)-758 is a miRNA that has been frequently studied in non-small cell lung cancer (20), hepatocellular carcinoma (21) and cervical cancer (22). However, to date, the expression patterns and roles of miR-758 in TSCC have remained largely unknown. In the present study, miR-758 expression in TSCC tissues and cell lines was detected and the detailed roles of miR-758 in TSCC progression were examined. Finally, the present study investigated the mechanisms underlying the action of miR-758 in TSCC cells. The results of the present study may provide a novel theoretical basis to better understand the biological roles of miR-758 in the development of TSCC.

Materials and methods

Tissue sample collection and cell culture

The present study was approved by the Ethics Committee of Affiliated Hospital of Inner Mongolia University for the Nationalities (Tongliao, China). Written informed consent was also provided by all patients with TSCC prior to their enrollment in the study. Primary TSCC tissues and corresponding adjacent non-tumorous tissues were obtained from 32 patients with TSCC (19 males, 13 females; age range, 41–67 years) who received surgical resection at Affiliated Hospital of Inner Mongolia University for the Nationalities between April 2014 and May 2016. All patients had not undergone chemotherapy or radiotherapy prior to surgery. Tissue specimens were immediately snap-frozen in liquid nitrogen and stored at −80°C until further use.

A total of three human TSCC cell lines (Tca8113, SCC-15, and CAL-27) and normal gingival epithelial cells were purchased from the American Type Culture Collection (Manassas, VA, USA). TSCC cell lines were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin (all Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Normal gingival epithelial cells were cultured in minimum essential media containing 10% heat-inactivated FBS and 1% penicillin-streptomycin. All these cells were grown at 37°C in a 95% air and 5% CO2 humidified incubator.

Oligonucleotides, plasmids and transfection

The miR-758 mimics and negative control miRNA mimics (miR-NC) were obtained from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). The miR-758 mimics sequence was 5′-UUUGUGACCUGGUCCACUAACC-3′ and the miR-NC sequence was 5′-UUCUCCGAACGUGUCACGUTT-3′. The full-length MTDH sequences was chemically synthesized by the Chinese Academy of Sciences (Changchun, China) and inserted into pcDNA3.1 (Thermo Fisher Scientific, Inc.), referred to as pcDNA3.1-MTDH. Cells were plated into 6-well plates with an initial density of 5×105 cells/well. Following incubation overnight, cell transfection was performed with miR-758 mimics (100 pmol), miR-NC (100 pmol), pcDNA3.1 (4 µg) or pcDNA3.1-MTDH (4 µg) using Lipofectamine® 2000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. Then, 48 h after transfection, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect miR-758 expression, while western blot analysis was employed to measure MTDH protein expression at 72 h post-transfection. Cell Counting kit-8 (CCK-8) and Transwell invasion assays were carried out at 24 and 48 h after transfection, respectively.

RT-qPCR

Total RNA was isolated from tissue specimens or cultured cells using TRIzol® reagent (Invitrogen; Thermo Fisher Scientific, Inc.), and was subjected to RNA purification using the RNeasy Maxi kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer's protocol. An All-in-One™ miRNA RT-qPCR Detection kit (GeneCopoeia, Inc., Rockville, MD, USA) was utilized to analyze miR-758 expression, with U6 small nucleolar RNA as an internal control. The assay was performed using the standard 3-step method. First: 10 min at 95°C; second, 40 cycles of 95°C for 10 sec, 60°C for 20 sec and 72°C for 10 sec; and finally, 6 sec at 95°C, and 20 sec at 30°C. For the identification of MTDH mRNA expression, single stranded cDNA was produced using a PrimeScript® RT reagent kit (Takara Bio, Inc., Otsu, Japan). The temperature protocols of reverse transcription were: 37°C for 15 min and 85°C for 5 sec. Subsequently, qPCR was conducted using a SYBR Premix ExTaq kit (Takara Bio, Inc.), in accordance with the manufacturer's protocol. The thermocycling conditions for qPCR were: 5 min at 95°C, followed by 40 cycles of 95°C for 30 sec and 65°C for 45 sec. GAPDH was used an internal reference for MTDH expression. The primers were designed as follows: miR-758 forward, 5′-ACACTCCAGCTGGGTTTGTGACCTGGTCCA-3′ and reverse, 5′-TGGTGTCGTGGAGTCG-3′; U6 forward, 5′-GCTTCGGCAGCACATATACTAAAAT-3′ and reverse, 5′-CGCTTCACGAATTTGCGTGTCAT-3′; MTDH forward, 5′-TGCCTCCTTCACAGACCAA-3′ and reverse, 5′-TCGGCTGCAGATGAGATAG-3′; and GAPDH forward, 5′-GGAGCGAGATCCCTCCAAAAT-3′ and reverse, 5′-GGCTGTTGTCATACTTCTCATGG-3′. Relative gene expression was quantified by the 2−ΔΔCq method (23).

CCK-8 assay

The CCK-8 assay was conducted to determine the proliferative ability of TSCC cells. Transfected cells were collected at 24 h post-transfection, and were plated into 96-well plates at a density of 2×103 cells/well. At 0, 24, 48 and 72 h after inoculation, a total of 10 µl CCK-8 solution (Dojindo Molecular Technologies, Inc., Kumamoto, Japan) was added into each well. After an additional 2 h of incubation, the absorbance value was detected at 450 nm wavelength using a microplate spectrophotometer (BioTek Instruments, Inc., Winooski, VT, USA).

Transwell invasion assay

A Transwell invasion assay was performed using Transwell chambers (8 µm) that were precoated with Matrigel (both BD Biosciences, San Jose, CA, USA). After incubation for 48 h, 1×105 transfected cells were suspended in FBS-free RPMI 1640 medium, and were seeded into the upper compartments of the Transwell chambers. The lower compartments were covered with 500 µl RPMI-1640 medium supplemented with 20% FBS. Transwell chambers were incubated at 37°C with 5% CO2 for 24 h prior to the removal of the non-invasive cells using a cotton swab. The invasive cells were fixed with 100% methanol at 37°C for 30 min, stained in 0.1% crystal violet at 37°C for 30 min and photographed under an inverted microscope (magnification, ×200; Olympus Corporation, Tokyo, Japan). The invasive ability of TSCC cells was determined by counting the average number of invaded cells in five randomly selected fields in each chamber.

Bioinformatics analysis

The putative targets of miR-758 were predicted using TargetScan (www.targetscan.org) and microRNA.org (www.microrna.org). Bioinformatics analysis indicated that MTDH may be a target of miR-758.

Luciferase reporter assay

The 3′-UTR fragments of MTDH containing the wild-type (wt) and mutant (mut) binding sequences were synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China). These fragments were inserted into the pMIR-REPORT vector (Promega Corporation, Madison, WI, USA), referred to as pMIR-MTDH-3′-UTR wt and pMIR-MTDH-3′-UTR mut. Cells in 24-well plates were co-transfected with pMIR-MTDH-3′-UTR wt or pMIR-MTDH-3′-UTR mut, and miR-758 mimics or miR-NC, using Lipofectamine 2000, following the manufacturer's protocol. Transfected cells were incubated at 37°C under 95% air and 5% CO2 for 48 h. Luciferase activity was tested with a dual-Luciferase Reporter Assay system (Promega Corporation, Madison, WI, USA), in accordance with the manufacturer's protocol. Firefly luciferase activity was used for normalization.

Western blot analysis

Total protein was isolated using a radioimmunoprecipitation assay buffer (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) from tissue specimens or cultured cells. Protein concentration was detected using a bicinchoninic acid protein assay (Sigma-Aldrich; Merck KGaA). Equal amounts of protein (30 µg) were resolved via 10% SDS-PAGE, and transferred to PVDF membranes (EMD Millipore, Billerica, MA, USA). Subsequently, the membranes were blocked in 5% non-fat milk in TBS containing 0.1% Tween-20 (TBST) at room temperature for 2 h. The membranes were incubated with primary antibodies against MTDH (1:1,000 dilution; cat. no. sc-517220) or GAPDH (1:1,000 dilution; cat. no. sc-69778; both Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4°C overnight. Following three washes with TBST, the membranes were further incubated with goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1:5,000 dilution; cat. no. sc-516102; Santa Cruz Biotechnology, Inc.), following by visualizing the protein bands with Enhanced Chemiluminescence™ Western Blotting Detection Reagents (GE Healthcare Life Sciences, Little Chalfont, UK). GAPDH was used as a loading control. Densitometric analysis. was performed using Quantity One software version 4.62 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Statistical analysis

Statistical analysis was performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). All data are presented as the mean ± standard deviation. The data were analyzed using a Student's t-test or one-way analysis of variance (ANOVA). Student-Newman-Keuls was used as a post hoc test following ANOVA. The association between miR-758 and MTDH mRNA expression levels in TSCC tissues was measured using Spearman's correlation analysis. All functional assays were performed at least three times. P<0.05 was considered to indicate a statistically significant difference.

Results

miR-758 is downregulated in TSCC tissues and cell lines

To reveal the role of miR-758 in the progression of TSCC, the total RNA was extracted from 32 pairs of TSCC tissues and corresponding adjacent non-tumorous tissues. Subsequently, miR-758 expression levels were determined in the tissues through RT-qPCR. The results indicated that miR-758 expression level was significantly lower in TSCC tissues compared with non-tumorous tissues (Fig. 1A; P<0.05). To confirm this observation, we further detected miR-758 expression levels in three TSCC cell lines (Tca8113, SCC-15 and CAL-27) and normal gingival epithelial cells. miR-758 was downregulated in TSCC cell lines relative to the normal gingival epithelial cells (Fig. 1B; P<0.05). The present results suggested that miR-758 was downregulated in TSCC, and the downregulation of miR-758 may be associated with TSCC development.

Figure 1. miR-758 is underexpressed in TSCC tissues and cell lines. (A) RT-qPCR analysis was utilized to detect the expression of miR-758 in 32 pairs of TSCC tissues and corresponding adjacent non-tumorous tissues. U6 small nucleolar RNA was used as an internal control. *P<0.05. (B) miR-758 expression in three TSCC cell lines (Tca8113, SCC-15 and CAL-27) and normal gingival epithelial cells was determined using RT-qPCR. *P<0.05 vs. normal gingival epithelial cells. TSCC, tongue squamous cell carcinoma; miR, microRNA; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.

Overexpression of miR-758 inhibits cell proliferation and invasion in TSCC

Tca8113 and CAL-27 cell lines exhibited lower miR-758 expression levels compared with the SCC-15 cell line; therefore, these cell lines were used to examine the biological roles of miR-758 in TSCC progression. miR-758 mimics or miR-NC were introduced into the Tca8113 and CAL-27 cells, and RT-qPCR analysis was performed. The results revealed that miR-758 expression was significantly higher in the miR-758 mimics-transfected Tca8113 and CAL-27 cells (Fig. 2A; P<0.05). Analysis of cell proliferation using the CCK-8 assay indicated that miR-758 upregulation significantly suppressed Tca8113 and CAL-27 cell proliferation compared with that in cells transfected with miR-NC (Fig. 2B; P<0.05). The effect of miR-758 restoration on TSCC cell invasion was measured by Transwell invasion assay. Fig. 2C illustrates that the invasive ability of Tca8113 and CAL-27 cells was reduced following miR-758 overexpression (P<0.05). These results suggested that miR-758 may be involved in the regulation of TSCC cell proliferation and invasion.

Figure 2. Effects of miR-758 upregulation on the proliferation and invasion of TSCC cells in vitro. (A) Reverse transcription-quantitative polymerase chain reaction analysis was used to measure the miR-758 expression following Tca8113 and CAL-27 cell transfection with miR-758 mimics or miR-NC. *P<0.05 vs. miR-NC. (B) A Cell Counting kit-8 assay was performed to evaluate the proliferative ability of Tca8113 and CAL-27 cells that were treated with miR-758 mimics or miR-NC. *P<0.05 vs. miR-NC. (C) The Transwell invasion assay indicated cell invasion following Tca8113 and CAL-27 cell transfection with miR-758 mimics or miR-NC (magnification, ×200). *P<0.05 vs. respective miR-NC group. NC, negative control; miR, microRNA.

MTDH is a direct target of miR-758 in TSCC cells

To illustrate the mechanism underlying the action of miR-758 in TSCC cells, bioinformatics analysis was applied to predict the putative targets of miR-758. MTDH was predicted as a major target of miR-758, and the 3′-UTR of MTDH contained a predicted binding site for miR-758 (Fig. 3A). This was selected for further experimental confirmation, since MTDH serves essential roles in the occurrence and development of TSCC (24–26). Luciferase reporter plasmids were conducted and used in luciferase reporter assays to determine whether the 3′-UTR may be directly targeted by miR-758. miR-758 overexpression significantly decreased the luciferase activity of the plasmid harboring the wt predicted binding sites in the Tca8113 and CAL-27 cells (P<0.05); however, this suppressive effect was not observed in the plasmid carrying the mutant binding sequences (Fig. 3B). Furthermore, the mRNA and protein expression levels of MTDH in the Tca8113 and CAL-27 cells under upregulation of miR-758 were examined. The results demonstrated that the restoration of miR-758 expression suppressed MTDH expression in the Tca8113 and CAL-27 cells at the mRNA (Fig. 3C; P<0.05) and protein (Fig. 3D; P<0.05) levels. These results suggested that MTDH may be a direct target gene of miR-758 in TSCC cells.

Figure 3. miR-758 directly targets MTDH in TSCC cells. (A) The predicted binding sites for miR-758 in the 3′-UTR of MTDH. The mutant binding sequences in the 3′-UTR of MTDH are also indicated. (B) miR-758 mimics or miR-NC was cotransfected with pMIR-MTDH-3′-UTR wt or pMIR-MTDH-3′-UTR mut into Tca8113 and CAL-27 cells. miR-758 overexpression obviously inhibited the luciferase activity of pMIR-MTDH-3′-UTR wt, but not the pMIR-MTDH-3′-UTR mut luciferase activity, in Tca8113 and CAL-27 cells. (C) Reverse transcription-quantitative polymerase chain reaction and (D) western blot analysis were used to detect MTDH mRNA and protein expression in Tca8113 and CAL-27 cells following transfection with miR-758 mimics or miR-NC. *P<0.05 vs. respective miR-NC group. UTR, untranslated region; mut, mutant; wt, wild-type; miR, microRNA; NC, negative control; MTDH, metadherin.

MTDH expression is inversely correlated with miR-758 expression in TSCC tissues

As MTDH was confirmed to be a direct target gene of miR-758, the present study further investigated the association between miR-758 and MTDH in TSCC. The mRNA and protein expression levels of MTDH were determined in TSCC tissues and corresponding adjacent non-tumorous tissues via RT-qPCR and western blot analysis, respectively. MTDH mRNA (Fig. 4A; P<0.05) and protein (Fig. 4B and C; P<0.05) expression was increased in the TSCC tissues compared with that in the adjacent non-tumorous tissues. Furthermore, the mRNA expression level of MTDH in the TSCC tissues was negatively correlated with miR-758 level (Fig. 4D; r=−0.5360, P=0.0016).

Figure 4. Expression of miR-758 is inversely correlated with MTDH expression in TSCC tissues. (A) MTDH mRNA expression was detected in 32 pairs of TSCC tissues and corresponding adjacent non-tumorous tissues. *P<0.05. (B) Representative western blot analysis and (C) quantification of MTDH protein expression in TSCC tissues and corresponding adjacent non-tumorous tissues. *P<0.05 vs. non-tumorous tissues. (D) A statistically significant negative association was determined between miR-758 and MTDH mRNA expression levels in TSCC tissues. r=−0.5360, P=0.0016. MTDH, metadherin; TSCC, tongue squamous cell carcinoma; N, non-tumorous; T, tumorous; miR, microRNA.

MTDH restoration abolishes the inhibitory effects of miR-758 on TSCC cells

Rescue experiments were performed to further determine whether MTDH mediates the suppressive roles of miR-758 in TSCC cells. MTDH overexpression plasmid (pcDNA3.1-MTDH) lacking the 3′-UTR was used for the restoration of MTDH expression. Tca8113 and CAL-27 cells were transfected with pcDNA3.1-MTDH or empty pcDNA3.1 plasmid. The results of the western blot analysis demonstrated that MTDH protein expression was efficiently upregulated in the Tca8113 and CAL-27 cells transfected with pcDNA3.1-MTDH (Fig. 5A; P<0.05). In addition, miR-758 mimics, together with pcDNA3.1-MTDH or empty pcDNA3.1 plasmid, were transfected into Tca8113 and CAL-27 cells. MTDH protein expression was restored in the Tca8113 and CAL-27 cells co-transfected with miR-758 mimics and pcDNA3.1-MTDH compared with that in cells co-transfected with miR-758 mimics and empty pcDNA3.1 plasmid (Fig. 5B and C; P<0.05). Furthermore, the results of the functional assays confirmed that MTDH restoration significantly counteracted the suppressive effects of miR-758 overexpression on the proliferation (Fig. 5D; P<0.05) and invasion (Fig. 5E; P<0.05) of Tca8113 and CAL-27 cells. These results suggested that miR-758 may inhibit the biological behaviors of TSCC, at least partly by inhibiting MTDH expression.

Figure 5. MTDH mediates the suppressive roles of miR-758 overexpression in TSCC cells. (A) Western blot analysis was utilized to detect MTDH protein expression in Tca8113 and CAL-27 cells following transfection with pcDNA3.1-MTDH or pcDNA3.1. *P<0.05 vs. respective pcDNA3.1 group. (B) Tca8113 and (C) CAL-27 cells were cotransfected with miR-758 mimics and pcDNA3.1-MTDH or pcDNA3.1. Western blot analysis was used to measure MTDH protein expression. *P<0.05 vs. miR-NC. #P<0.05 vs. miR-758 mimics + pcDNA3.1-MTDH. (D) Cell Counting kit-8 and (E) Transwell invasion assays were performed to determine the proliferation and invasion (magnification, ×200) of Tca8113 and CAL-27 cells that were cotransfected with miR-758 mimics and pcDNA3.1-MTDH or pcDNA3.1. *P<0.05 vs. miR-NC; #P<0.05 vs. miR-758 mimics + pcDNA3.1-MTDH. miR, microRNA; MTDH, metadherin; NC, negative control.

Discussion

Numerous miRNAs are dysregulated in TSCC, and their dysregulation has been demonstrated to have a strong correlation with TSCC progression by repressing their target genes (11,18,27). Therefore, miRNAs have potential use in the diagnosis and treatment of patients with TSCC. The present study demonstrated that miR-758 was weakly expressed in TSCC tissues and cell lines. Exogenous miR-758 disrupted the proliferation and invasion of TSCC cells. Additionally, miR-758 directly targeted the 3′-UTR of MTDH in TSCC cells and reduced its expression at the mRNA and protein levels. It was also demonstrated that MTDH mRNA and protein expression levels were increased in TSCC tissues compared with non-tumorous tissues. Furthermore, miR-758 levels were negatively correlated with the MTDH mRNA expression level in TSCC tissues. Moreover, restoration of MTDH expression offset the inhibitory effects of miR-758 overexpression on TSCC cell proliferation and invasion. These results suggested that miR-758 serves tumor-suppressive roles in TSCC by directly targeting MTDH.

The expression and roles of miR-758 have been well studied in a number of types of human cancer. miR-758 is downregulated in non-small cell lung cancer tissues, and the downregulation of miR-758 is significantly correlated with tumor, node, metastasis stage. Patients with non-small cell lung cancer with low miR-758 expression exhibit shorter overall survival times compared with patients with high miR-758 levels (20). In hepatocellular carcinoma, miR-758 expression is reduced in tumor tissues and cell lines. Moreover, the upregulation of miR-758 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma (21). miR-758 is also underexpressed in cervical cancer tissues, blood cells and cervical exfoliated cells. The underexpression of miR-758 is strongly associated with the infiltration and invasion of cervical cancer (22). Therefore, miR-758 has potential applications for the diagnosis and treatment of patients with these specific cancer types.

miRNAs are closely associated with tumorigenesis and tumor development by directly binding to the 3′-UTR of their target genes. Therefore, identifying the target genes of miR-758 in TSCC is critical for understanding the mechanism underlying the pathogenesis of TSCC, and is also essential for examining novel therapeutic targets for treating patients with this malignancy. MTDH, located on chromosome 8q22, was validated as a direct target gene of miR-758 in TSCC cells. It was first discovered in human fetal astrocytes in 2002 and is also termed astrocyte elevated gene-1 (28). MTDH is upregulated in multiple types of human cancer, including breast cancer (29), gastric cancer (30), thyroid carcinoma (31), and cervical cancer (32). MTDH contributes to the regulation of cancer oncogenesis and progression and regulates cell proliferation, cell cycle, apoptosis, metastasis, epithelial-to-mesenchymal transition and angiogenesis (33–35).

MTDH is overexpressed in TSCC tissues and cell lines (24,25). High MTDH expression is associated with the degree of differentiation, clinical stage, tumor classification, node classification and metastasis. Patients with TSCC exhibiting high MTDH expression have shorter overall survival time compared with those with low MTDH levels (25). Through multivariate analysis, MTDH was identified as an independent prognostic biomarker for the prediction of the prognosis of patients with TSCC (25,26). MTDH exerts its oncogenic effects on TSCC cells by affecting cell invasion and epithelial-mesenchymal transition (26). In the present study, it was demonstrated that miR-758 directly targets MTDH to inhibit the development of TSCC. These results support the notion that the miR-758/MTDH pathway is a useful therapeutic target for the management of patients with TSCC.

In conclusion, miR-758 expression was downregulated in TSCC tissues and cell lines. Functional assays demonstrated that cell proliferation and invasion in TSCC was supressed by increasing miR-758 expression. MTDH was identified to be a direct target of miR-758 in TSCC. The results of the present study may enhance our understanding of the molecular mechanisms of miR-758 in regulating the development of TSCC. The present results suggested that miR-758-based targeted therapy against MTDH expression is a potential therapeutic technique for patients with TSCC. One miRNA may directly target numerous genes; however, the present study only determined MTDH to be a direct target gene of miR-758 in TSCC. This is a limitation of the study, and other targets of miR-758 may be examined in further experiments.

Acknowledgements

Not applicable.

Funding

The present study was supported by the Natural Science Foundation of Inner Mongolia Autonomous Region (grant no. 2015MS0876).

Availability of data and materials

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

Authors' contributions

YZ and FZ designed this research, and performed functional experiments. The authors have read and approved the final draft.

Ethics approval and consent to participate

The present study was approved by the Ethics Committee of Affiliated Hospital of Inner Mongolia University for the Nationalities, and was performed in accordance with the Declaration of Helsinki and the guidelines of the Ethics Committee of Affiliated Hospital of Inner Mongolia University for the Nationalities. Written informed consent was obtained from all patients for the use of their clinical tissues.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References